Doxorubicin-enriched, ALDH(br) mouse breast cancer stem cells are treatable to oncolytic herpes simplex virus type 1
about
Aldehyde dehydrogenase as a marker and functional mediator of metastasis in solid tumorsOncolytic virotherapy using herpes simplex virus: how far have we come?High efficiency of alphaviral gene transfer in combination with 5-fluorouracil in a mouse mammary tumor model.A simple in vitro method for evaluating dendritic cell-based vaccinations.New Insights on Glucosylceramide Synthase in Cancer Drug Resistance and Myelosuppression.Doxorubicin synergizes with 34.5ENVE to enhance antitumor efficacy against metastatic ovarian cancer.A novel oncolytic herpes simplex virus type 2 has potent anti-tumor activityA novel oHSV-1 targeting telomerase reverse transcriptase-positive cancer cells via tumor-specific promoters regulating the expression of ICP4Tumor-selective replication herpes simplex virus-based technology significantly improves clinical detection and prognostication of viable circulating tumor cells.Antitumor effects of oncolytic herpes simplex virus type 2 against colorectal cancer in vitro and in vivo.Oncolytic viral therapy: targeting cancer stem cellsCalpain-dependent clearance of the autophagy protein p62/SQSTM1 is a contributor to ΔPK oncolytic activity in melanoma.Oncolytic Immunotherapy for Treatment of Cancer.Transforming doxorubicin into a cancer stem cell killer via EpCAM aptamer-mediated delivery.
P2860
Q26786476-D3708CFD-1DCE-482B-816D-9B1EC6152082Q26862461-008A6075-0A55-43F9-A38F-29C3647C2EE6Q33828697-7D9D719C-B6B1-45BC-9966-312DACBE59F1Q34093643-92DCCA8C-664E-41AD-9A4F-6B87FF322D21Q34499844-D4CFAD62-AEE2-4A17-B6B7-33E291B1451FQ34715771-72032A20-3680-49CC-BCF7-9BADF45D0950Q35132272-8144F0A5-E499-4C7A-9D3C-A26471F50D6BQ36299683-92705551-5014-4FD0-8BFD-592BEEEC9806Q37457668-BF5CE536-B42A-46FA-AC07-8BA9B7DBD45EQ37641458-087B0C27-0E97-44D3-A211-EDF3698E8ABFQ38212255-AB4D5694-8C28-4694-B3EC-E68C7FAC34BCQ38615069-F0B6AAF7-2D66-4A30-A3F8-AD39B07966F8Q38848223-E9AEB664-8967-458C-9AC1-59CEE3305A54Q47108689-BCDE173F-CE12-44BD-8ECE-8BDFA539E17E
P2860
Doxorubicin-enriched, ALDH(br) mouse breast cancer stem cells are treatable to oncolytic herpes simplex virus type 1
description
2012 nî lūn-bûn
@nan
2012 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
name
Doxorubicin-enriched, ALDH(br) ...... ic herpes simplex virus type 1
@ast
Doxorubicin-enriched, ALDH(br) ...... ic herpes simplex virus type 1
@en
Doxorubicin-enriched, ALDH(br) ...... ic herpes simplex virus type 1
@nl
type
label
Doxorubicin-enriched, ALDH(br) ...... ic herpes simplex virus type 1
@ast
Doxorubicin-enriched, ALDH(br) ...... ic herpes simplex virus type 1
@en
Doxorubicin-enriched, ALDH(br) ...... ic herpes simplex virus type 1
@nl
prefLabel
Doxorubicin-enriched, ALDH(br) ...... ic herpes simplex virus type 1
@ast
Doxorubicin-enriched, ALDH(br) ...... ic herpes simplex virus type 1
@en
Doxorubicin-enriched, ALDH(br) ...... ic herpes simplex virus type 1
@nl
P2093
P2860
P356
P1433
P1476
Doxorubicin-enriched, ALDH(br) ...... ic herpes simplex virus type 1
@en
P2093
Binlei Liu
Shuren Zhang
Xiangping Han
Xiufen Zhuang
Yatong Chen
Youhui Zhang
P2860
P2888
P356
10.1186/1471-2407-12-549
P407
P577
2012-11-23T00:00:00Z
P5875
P6179
1032465652